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Epithelium of the colon and intestine are renewed
every 3 days. In the intestine there are at least two
principal stem cell pools. The first contains rapid
cycling crypt-based columnar (CBC) Lgr5+ cells,
and the second is composed of slower cycling
Bmi1-expressing cells at the +4 position above the
crypt base. In the colon, however, the identification
of Lgr5 stem cell pools has proven more chal-
lenging. Here, we demonstrate that the intermediate
filament keratin-19 (Krt19) marks long-lived, radia-
tion-resistant cells above the crypt base that
generate Lgr5+ CBCs in the colon and intestine. In
colorectal cancer models, Krt19+ cancer-initiating
cells are also radioresistant, while Lgr5+ stem cells
are radiosensitive. Moreover, Lgr5+ stem cells are
dispensable in both the normal and neoplastic
colonic epithelium, as ablation of Lgr5+ stem cells
results in their regeneration from Krt19-expressing
cells. Thus, Krt19+ stem cells are a discrete target
relevant for cancer therapy.
INTRODUCTION
Adult tissue stem cells are characterized by multipotentiality and
the capacity to self-renew (Li and Clevers, 2010). In the mouse
small intestine and colon, the simple columnar epithelium is
rapidly renewed every 3 days. Genetic-inducible fate-mapping
studies suggest that epithelial cells in the small intestine are
replaced from at least two principal stem cell pools, comprising
both rapidly cycling crypt-based columnar (CBC) Lgr5-express-
ing cells and slower cycling Bmi1-expressing stem cells situated
at position +4 above the crypt base (Barker et al., 2007;Sangiorgi and Capecchi, 2008). In the small intestine, the stem
cell markers Sox-9 and Hes1 are also expressed in actively
cycling Lgr5+ cells, while Bmi-1, mTert, Hopx, and Lrig1 are
expressed in relatively quiescent stem cells, confirming the exis-
tence of more than one stem cell pool (Fre et al., 2011; Furuyama
et al., 2011; Montgomery et al., 2011; Powell et al., 2012; Takeda
et al., 2011). Moreover, Lgr5+ cells are dispensable in the small
intestine, with Bmi1+ stem cells able to regenerate Lgr5+ cells
and their lineages (Tian et al., 2011).
The epithelial lining of the colon is also comprised of a single
layer of columnar epithelial cells, which are constantly renewed
by a pool of committed stem cells. These colonic stem cells
give rise to progeny that terminally differentiate into a number
of lineages that include colonocytes, mucus-secreting goblet
cells, and enteroendocrine cells. Most recent studies have sug-
gested that colonic stem cells are located at the crypt base
throughout the colon, and a number of markers for colon stem
cells have been proposed, including Lgr5 (Barker et al., 2007),
Lrig1 (Powell et al., 2012), Sox9 (Ramalingam et al., 2012), and
EphB2 (Jung et al., 2011). Lgr5 has been the best studied, with
in vivo lineage tracing showing that Lgr5-expressing cells at
the colonic crypt base are capable of self-renewal and able to
differentiate into all three colonic lineages. In the colon, however,
it has beenmore challenging to identify the stem cells that reside
above the crypt base. Bmi1+ cells, for example, do not exist in
the colon. Thus, it is not known whether more than one distinct
stem cell pool exists in the colon.
Tumors are postulated to arise from tissue stem or progenitor
cells, but the relative contribution of different stem cell pools to
tumorigenesis remains unknown (Barker et al., 2009). In addition,
our current understanding of colon cancer is based on amodel of
clonal evolution, whereby early adenomas advance to invasive
carcinomas through stepwise acquisition of mutations (Fearon
and Vogelstein, 1990). In rapidly proliferating tissues, such as
the intestine or colon, however, this model of tumorigenesis
implies that only stem cells are sufficiently long-lived to accumu-
late the requisite mutations. Indeed, the contribution of Lgr5+Cell Stem Cell 16, 627–638, June 4, 2015 ª2015 Elsevier Inc. 627
stem cells to intestinal tumorigenesis has been demonstrated by
the formation of adenomas upon targeted mutation of the Apc
gene specifically in Lgr5+ cells (Barker et al., 2009). Nonetheless,
the contribution of additional Lgr5-negative stem cells to the
cellular origin of both colonic and intestinal cancer has not
been clarified.
To determine if an Lgr5-negative stem cell contributes to
colonic homeostasis and tumor initiation, we established a
genetic fate-mapping system for labeling keratin-19 (Krt19)-
expressing progenitor/stem cells. Cytokeratins are a multigene
family of intermediate filaments, critical in the maintenance of
the cytoskeleton but expressed in different lineages within the
epithelium (Moll et al., 1982). Cytokeratin 19 or Krt19 is the
smallest known acid keratin (40 kDa), is epithelial specific,
and is found in a broad range of epithelial tissues. In the gastro-
intestinal tract, Krt19 expression is restricted to the proliferating
compartments of the stomach, small intestine, and colon, as
well as the pancreatic ducts of the adult pancreas and the hep-
atobiliary ducts (Brembeck et al., 2001). Krt19 is expressed in
the stem cell zone of the hair follicle (Brembeck et al., 2001;
Lapouge et al., 2011; Means et al., 2008), is amplified in
many solid tumors, and, as we demonstrate here, is expressed
near the presumptive progenitor/stem cell zone of both the co-
lon and intestine. More specifically, we examined Krt19
because it is expressed at position +4, extending up to the
isthmus, thus allowing us to selectively label a population of
cells that includes transit-amplifying cells, progenitors, and
long-lived stem cells, yet excludes rapidly cycling CBC Lgr5+
stem cells.
We compared Krt19+ cells above the crypt base to Lgr5+
CBC cells with respect to their response to epithelial injury
and cancer-initiating ability. Krt19-expressing cells identify
long-lived progenitors/stem cells distinct from Lgr5+ cells and
additionally render Lgr5+ stem cells dispensable in both the
colon and intestine. Under conditional loss of the Apc gene,
Krt19+ stem cells also display cancer-initiating ability, yet are
functionally distinct from Lgr5+ cancer-initiating cells by their
relative radioresistance.
RESULTS
Krt19 Transcript Localizes to the Stem Cell Zone above
the Crypt Base and Marks Both Colonic and Intestinal
Stem Cells
To localize Krt19 mRNA and protein expression, we performed
in situ hybridization for Krt19 mRNA and immunofluorescence
staining for Krt19 protein. Krt19 RNA was completely absent
from the colonic crypt base and was detected primarily in the
isthmus (i.e., area of crypt narrowing) that included cells extend-
ing down near the presumptive crypt progenitor/stem cell zone
(Figure 1A; Figure S1A). In contrast, Krt19 protein showed min-
imal overlap with Krt19 RNA and was localized predominantly in
differentiated cells (Figure S1B). Similarly, in the intestine, Krt19
RNA was detected primarily in the isthmus, and not in the intes-
tinal crypt base (Figures 1B and S1B), while Krt19 protein
expression localized to differentiated cells of the intestinal villus
(Figure S1D). We have previously reported a progenitor/stem
cell marker in the stomach that similarly displayed a discrep-
ancy in the pattern between RNA versus protein expression628 Cell Stem Cell 16, 627–638, June 4, 2015 ª2015 Elsevier Inc.(Quante et al., 2010), so we sought to examine whether Krt19
also marked a stem cell population. We developed a Krt19-
BAC-mApple (Krt19-mApple) reporter mouse (Figure S1I), con-
firming that Krt19 gene expression was limited only to cells
located well above the crypt base in both the colon (Figure 1C)
and intestine (Figure 1D). Notably, the absence of both Krt19
mRNA and protein expression from the crypt base (Figures
1A–1D; Figures S1A–S1H) afforded us the unique opportunity
to selectively label and compare a progenitor/stem cell pool sit-
uated above the crypt base (position +4) to the well described
Lgr5+ CBC cells (Barker et al., 2007) and the more recently
reported Lrig1+ stem cells (Powell et al., 2012) found at the crypt
base.
To identify an Lgr5-negative progenitor/stem cell pool in the
colon, we established a genetic fate-mapping system for label-
ing Krt19. We generated a Krt19-BAC-CreERT2 (Krt19-CreERT)
transgenic line (Figures S1J and S1K) that was crossed to R26-
LacZ (R26-LacZ) and ROSA26-mT/mG (R26-mT/mG) reporters
in order to perform genetic lineage tracing experiments in
homeostasis, inflammation, and cancer. Shortly following
tamoxifen induction, b-galactosidase+ (b-gal) cells were local-
ized to the colonic crypt (Figure 1E) in a pattern identical to
Krt19-expressing cells detected by in situ and Krt19-mApple+
cells detected using a Krt19-mApple transgenic reporter mouse.
Twenty-four hours after tamoxifen, recombination was evident in
the colonic isthmus, extending down to the +4 position, but
distinctly above the crypt base (Figures 1G and S2A). One
week following tamoxifen, recombined cells derived from
Krt19+ cells extended downward to include Lgr5+ cells at the
colonic crypt base (Figures 1G and S2A). Sixteen weeks post-
induction, Krt19+ cells traced all epithelial cell lineages in the
colon (Figures 1G and S2A), and completely labeled glands
were detected without any loss of labeling beyond 52 weeks
(Figure 1G; Figures S2A–S2D), consistent with Krt19 labeling
long-lived stem cells.
In vitro, two-photon florescence microscopy of colonic crypts
isolated from Krt19- CreERT;R26-mT/mG mice 12 hr after a sin-
gle dose of tamoxifen also revealed recombination (GFP+) in a
number of Krt19-expressing cells above the crypt base (Figures
1I and 1J; n = 6, colon). These cells contained bona fide stem
cells and gradually replaced all epithelial cells over 9–10 days
(colon: Figures 1I and 1J).
Similarly, in the intestine, genetic lineage tracing experiments
revealed that shortly following tamoxifen induction, Krt19-
labeled b-gal+ cells located clearly above the crypt base in the
intestinal crypt (Figures 1K and S2E). These cells eventually
traced all intestinal epithelial cell lineages, including Lgr5+ cells
at the crypt base (Figure 1K; Figures S2E and S2F), and again,
consistent with the labeling of long lived stem cells, we observed
no loss of labeling beyond 52 weeks (Figures 1C and 1D).
Furthermore, in intestinal enteroids grown in vitro, a few Krt19+
cells above the crypt base could be detected 12 hr following
tamoxifen (Figures S2G–S2I; n = 4, intestine), and these cells
expanded over 9–10 days to replace the entire crypt-villus col-
umn (Figures S2G–S2I). Single-cell culture of Krt19-mApple+
cells isolated from the intestine of Krt19-mApple reporter mice
further confirmed the stem cell capacity of Krt19+ cells (Fig-
ure S2J) at 1% clonogenic efficiency compared to 5% for
Lgr5-GFP+ cells.
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Figure 1. Krt19 mRNA Localizes to the
Colonic and Intestinal Stem Cell Zone and
Marks Long-Lived Stem Cells
(A and B) Krt19mRNA is expressed in the isthmus
extending down to the +4 position of the colonic
(A) and (B) intestinal crypt. High-magnification
images of the crypt base are shown as insets.
(C and D) Krt19-mApple+ cells in the colon (C) and
small intestine (D) of Krt19-mApple reporter mice
show expression similar to in situ.
(E and F) 24 hr post-tamoxifen, b-gal+ colonic (E)
and intestinal (F) crypts in Krt19-CreERT;R26R-
LacZ mice also show expression identical to
in situ.
(G) Lineage tracing in the colon of Krt19-
CreERT;R26RLacZ mice. High-magnification im-
ages of the crypt base are shown at 24 hr and
52 weeks following tamoxifen (6 mg per os [p.o.]).
(H) Low-magnification images of lineage tracing in
the colon of Krt19-CreERT;R26RLacZ 26 weeks
following tamoxifen (nR 7 per group).
(I and J) Bright-field (6 and 24 hr after culture) (I)
and two-photon images (24 hr and 9 days
following tamoxifen [6 mg p.o.]) (J) of colonic
crypts from Krt19-CreERT; R26-mT/mGmice (nR
4 per group) cultured in vitro.
(K) Lineage tracing in the intestine in Krt19-
CreERT/R26RLacZ mice with high-magnification
images of the crypt base shown at 24 hr to
52 weeks following tamoxifen (6 mg p.o.). Black
arrows show Krt19-derived CBCs at 7 days and
Paneth cells at 16 and 52 weeks.
(L) Low-magnification images of lineage tracing
in the intestine of Krt19-CreERT/R26RLacZ
26 weeks following tamoxifen (nR 7 per group).
See also Figures S1 and S2.Krt19+-Potential Stem Cells above the Crypt Base Are
Distinct from Lgr5+ CBCs
To measure the overlap of Krt19+ cells with Lgr5+ cells, we per-
formed Krt19 in situ hybridization on colonic (Figure 2A) tissues
of Lgr5-EGFP-IRES-CreERT2 mice. We confirmed that Krt19
mRNA expression was not detectable in CBC stem cells marked
by Lgr5 and overlapped rarely with a very small subset of Lgr5-
GFP-positive cells located much higher in the colonic crypt
(average position +7) (Figure 2C). Similarly, Krt19mRNA expres-
sionwas not detectable in Lgr5+ CBCs in the intestine (Figure 2B)
and again overlapped rarely with a very small subset of Lgr5-
GFP-positive cells located much higher in the crypt (average
position +7) (Figure 2C). The majority of Krt19+ cells were also
distinct from Lgr5+ cells with respect to their proliferation status,
as most Lgr5+ cells were located immediately below the prolifer-
ation zone, whereas Krt19+ cells predominated within the prolif-
eration zone (12% Lgr5+/Ki67+ versus 50% Krt19+/Ki67+Cell Stem Cell 16, 627–cells) (Figures 2D–2F; Figures S3A–S3J).
Importantly, when we generated Krt19-
mApple;Lgr5-EGFP-IRES-CreERT2 dual
reporter mice, Krt19-mApple+/Lgr5-
GFP+ double-positive cells were only de-
tected in extremely rare cells located
higher in the colonic crypt (Figure 2G)
and comprised <0.05% of total epithelialcells and <6% of Lgr5-GFP+ cells as detected by FACS (Figures
2I and 2J; Figure S3K). Similarly, in the intestine, <0.01% of total
epithelial cells and <5%of Lgr5-GFP+ cells wereKrt19-mApple+/
Lgr5-GFP+ double-positive cells as determined by imaging (Fig-
ure 2H) and fluorescence-activated cell sorting (FACS) analysis
(Figures 2J and S3K). Thus, Krt19 and Lgr5 identify largely
distinct populations (Figure 2K), with only rare overlap near
the +7 cell region.
Interestingly, RNA expression analysis revealed that theKrt19-
mApple+/ Lgr5-GFP+ double-positive intestinal cells displayed
significant enrichment for the known ‘‘+4’’ intestinal stem cell
markers Bmi1, Hopx, and Lrig1, as well as the intestinal progen-
itor marker Dll1 (Figure 2L), whereas Lgr5-negative Krt19-
mApple+ cells showed relatively low or undetectable levels of
both ‘‘+4’’ stem cell and progenitor markers (Figure 2L). Remark-
ably, despite the heterogeneity of Krt19+ cells posing a poten-
tial confounding factor in this RNA expression analysis, we638, June 4, 2015 ª2015 Elsevier Inc. 629
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Figure 2. Krt19+ Cells Are Located above Lgr5+ Crypt Base Columnar Cells in the Colon and Intestine
(A and B) Colocalization of Krt19 mRNA-expressing cells (red) detected by in situ, and Lgr5-GFP+ cells (green) in the colon (A) and small intestine (B) of
Lgr5-EGFP-IRES-CreERT2 mice. White arrows denote double-positive cells.
(C) Average cell position of Krt19 mRNA-expressing (red) and Lgr5-EGFP+ (green) cells within the colonic (top panel) and intestinal (bottom panel) crypt.
(D and E) Colocalization of Ki67 and Lgr5-EGFP+ cells (D) versus Ki67 and Krt19-EGFP+ cells 12 hr after tamoxifen (E) in Lgr5-EGFP-IRES-CreERT2 or
Krt19-CreERT;ROSA26-mG/mT mice, respectively. Yellow arrow shows a rare double-positive (Ki67+, Lgr5-GFP+) cells, and white arrow shows a rare Krt19+,
Ki67 cells.
(F) Quantification of double-positive Ki67+Krt19+ cells (red bars) versus Ki67+Lgr5-GFP+ cells (green bars).
(legend continued on next page)
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confirmed using microscopy that only rare Krt19+/Bmi1+ cells
are detected in the crypts of Krt19-CreERT;ROSA26-Tomato
mice crossed to Bmi1-GFP mice (Figure S3L).
Thus, given the infrequent overlap ofKrt19 and Lgr5, we sought
to definitively distinguish between Krt19+ versus Lgr5+ cells. We
generated Lgr5-DTR-EGFP;Krt19-CreERT;R26-Tomato mice
to conditionally ablate Lgr5+ cells following administration of
diphtheria toxin, as previously described (Tian et al., 2011).
First, we confirmed at 24 hr following tamoxifen induction
that Krt19-Tomato+ cells were located above the crypt base
and were almost entirely distinct from Lgr5-GFP+ CBCs (Figures
3A and 3B). Next, we administered diphtheria toxin (DT) 3 days
prior to tamoxifen in order to ablate Lgr5+ cells before the
start of Krt19 lineage tracing (Figure 3C). Interestingly, Krt19+
colonic stem cells continued to lineage trace in the colon
and gave rise to new Lgr5-GFP+ cells when the diphtheria toxin
was stopped (Figure 3D). Importantly, the efficiency of Krt19+
cell-lineage tracing was unchanged despite Lgr5+ cell ablation
effectively eliminating both the Lgr5-GFP+ CBCs, as well as the
rare ‘‘+4’’Krt19-mApple+/Lgr5-GFP+double-positive cell popula-
tions (Figure 3E).
Similarly, Krt19+ cells in the intestine continued to lineage
trace and display resiliency in the face of Lgr5-GFP+ cell ablation
(Figure 3D). From these data, we conclude that Krt19+ lineage
tracing in the intestine was not due to overlap with the Dll1+
progenitor population for several reasons. First, Dll1 RNA
expression was predominantly detected within the rare ‘‘+4’’
Krt19-mApple+/Lgr5-GFP+ double-positive and Lgr5-GFP+
CBC populations, rather than within Krt19-mApple+ cells. More-
over, Dll1+ progenitors are reported to show no lineage tracing
capacity when irradiated 2 weeks after tamoxifen (van Es et al.,
2012) and, additionally, are unable to form intestinal enteroids
in the absence of Wnt3a (van Es et al., 2012). In contrast,
Krt19+ cells formed intestinal enteroids in the absence of
Wnt3a (Figures S4A–S4C) and also showed lineage tracing ca-
pacity in vivo when irradiated 2 weeks after tamoxifen (Figures
4K and 4L).
Krt19+ lineage tracing capacity was not due to overlap with
Krt19+ transit-amplifying (TA) cells. We used 5-fluorouracil
(5-FU) to target the rapidly proliferating TA cell population as
previously described (Doetsch et al., 1999; Stange et al.,
2013) and confirmed that this treatment eliminated nearly all
(> 95%) of the proliferating TA cells in both the colon and intes-
tine (Figures 3F–3H; Figure S4D). Krt19+ cells lineage traced
with the same efficiency in both the colon and intestine regard-
less of TA cell ablation alone, or TA cell plus Lgr5+ cell ablation
(Figures 3I and 3J). Taken together, these data prove that Krt19
identifies a novel Lgr5() Krt19-expressing potential stem cell
population in both the colon and intestine. Interestingly, Krt19(G andH) Representative images of the colon (G) and SI (H) ofKrt19-mApple;Lgr5-
and Lgr5-GFP+ cells in the colon and rare Krt19-mApple+/Lgr5-GFP+ double-po
(I and J) FACS plot (I) and quantification (J) of colonic and intestinal Krt19-m
CreERT2 mice.
(K) Schematic diagram of the intestinal crypt demonstrating the location of Krt19
(L) mRNA expression levels of + 4 stem cell (BMi1, Hopx, and Lrig1) and proge
Lgr5-GFP+ double-positive cell populations.
Data in all bar graphs are presented as mean ± SEM.
See also Figure S3.and Lgr5 additionally label distinct cell populations during
development. Using a newly generated, constitutive Krt19-
BAC-CRE transgenic mouse, we observed that Krt19 marked
the early gastrointestinal endoderm, raising the possibility that
Krt19may also label a stem cell population in development (Fig-
ures S5A–S5G). This is in contrast to Lgr5-GFP+ cells, which
were first detected in the intestine as weakly GFP+ cells on
post-natal day 5 (Figures S5H and S5I).
Krt19+ Cells Show Relative Radioresistance and Are
Functionally Distinct from Lgr5+ Stem Cells and Dll1+
Progenitors
Radiation injury initiates intestinal stemcell division during epithe-
lial repair (May et al., 2008; Yan et al., 2012), but Lgr5+ stem cells
have been proposed to be radiosensitive (van Es et al., 2012; Yan
et al., 2012), whereas Bmi1+ stem cells are radioresistant (Yan
et al., 2012). Thus, we sought to compare Krt19+ versus Lgr5+
stem cells with respect to their sensitivity to radiation. Krt19-
CreERT;R26-LacZ and Lgr5-EGFP-IRES-CreERT2;R26-LacZ
mice were irradiated (12 Gy) 24 hr following tamoxifen labeling
of each cell population (Figure 4A). When Lgr5-EGFP-IRES-
CreERT2;R26-LacZ mice were irradiated 24 hr after tamoxifen,
absence of lineage tracing (Figures 4Band4D; FigureS6A) imme-
diately following and in the early post-radiation period confirmed
that Lgr5+ cells were radiosensitive (Yan et al., 2012). Consistent
with Lgr5+ cell radiosensitivity, we observed a loss of Lgr5-GFP
expression immediately following radiation (Figure 4E). In con-
trast, radioresistantKrt19+ cells continued to lineage trace in irra-
diated Krt19-CreERT;R26-LacZ mice (Figures 4C and S6B), and
we detected an increase in contiguously labeled Krt19+ crypts,
consistent with crypt fission (Figure 4D) and stem cell expansion
through symmetric division as previously described (Park et al.,
1995). Moreover, the conclusion that radioresistance of Krt19+
cells was due to the labeling of stem cells, rather than TA cells,
was supported by our observations that targeting of TA cells
with 5-FUprior to radiation did not alter the lineage tracing capac-
ity of Krt19+ cells (Figures 4G and 4H). Krt19+ cells also showed
longevity (>18 months) well beyond the 2 week life span of Dll1+
progenitors and, importantly, showed lineage tracing capacity
even when irradiated 2 weeks following tamoxifen induction (Fig-
ures S6E and S6F).
To confirmour in vivo observations, we examined the effects of
radiation on intestinal enteroid growth and stem cell function
in vitro (Figure 4I). Following 10Gy irradiation, intestinal enteroids
from Krt19-mApple+/Lgr5-GFP+ dual reporter mice showed a
marked reduction in Lgr5-GFP+ stem cells associated with the
loss of crypt budding, suggesting crypt injury (Figures 4I
and 4J). In contrast, the same enteroids showed that Krt19-
mApple-expressing cells remained radioresistant and survivedEGFP-IRES-CreERT2 dual reporter mice showing no overlap ofKrt19-mApple+
sitive cells higher in the crypt of the SI.
Apple+ and Lgr5-GFP+-positive cells from Krt19-mApple;Lgr5-EGFP-IRES-
-expressing cells in relation to Lgr5+ crypt-based columnar cells.
nitor (Dll1) markers among Krt19-mApple+, Lgr5-GFP+, and Krt19-mApple+/
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Figure 3. Krt19+ Stem Cells Render Lgr5+ Stem Cells Dispensable in the Colon and Small Intestine
(A) Tamoxifen protocol used to analyze Krt19+ and Lgr5+ cells in Lgr5-DTR-EGFP;Krt19-CreERT/R26RTomato mice 24 hr post-tamoxifen.
(B) Images of the colon and SI 24 hr post-tamoxifen are shown.
(C and D) Diphtheria toxin (DT) ablation regimen (C) used in Lgr5-DTR-EGFP;Krt19-CreERT/R26RTomato mice showing Krt19+ stem cells (red) render Lgr5+ cells
(green) dispensable in the colon and SI (D).
(E) Quantification of Krt19+ stem cell lineage tracing efficiency in the presence or absence of Lgr5+ stem cells is shown.
(F) DT-induced Lgr5+ cells ablation and 5-FU-induced transit-amplifying (TA) cell ablation regimen used in Lgr5-DTR-EGFP;Krt19-CreERT/R26RTomato mice.
(G) Representative high-power view of Ki67+ cells in the colon of control (left) versus 5-FU-treated (right) mice.
(H) Quantification of Ki67+ cells in the colon or intestine of control versus 5-FU-treated mice.
(I) Krt19+ stem cells (red) render Lgr5+ cells (green) dispensable in the colon and SI in spite of 5-FU ablation of TA cells.
(J) Quantification of Krt19+ stem cell lineage tracing efficiency in the presence or absence of DT and/or 5-FU stem cells (I) is shown (nR 6 per group).
Data in all bar graphs are presented as mean ± SEM.
See also Figures S4 and S5.
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radiation injury. Indeed, during the regenerative state post-radia-
tion, newly budding crypts arose from radioresistant Krt19-mAp-
ple-labeled cells (Figure 4J). These data again confirmed our
in vivo observations that Krt19+ cells show relative radioresist-
ance when compared to Lgr5+ stem cells.
Recently, it was shown that interconversion can occur
between Hopx+ and Lgr5+ cells in vitro (Takeda et al., 2011)
and that Dll1+ progenitors can also revert back to an Lgr5+ state
in vitro (van Es et al., 2012). Thus, we examined whether radio-
sensitive Lgr5+ stem cells could give rise to radioresistant
stem cells in vivo. When we allowed for Lgr5 lineage tracing
to occur for up to 2 weeks prior to radiation (12 Gy) exposure,
we observed a significant increase in the number of contiguously
labeled Lgr5 traced SI crypts in Lgr5-EGFP-IRES-CreERT2;R26-
LacZ mice after radiation (Figures 4K4N; Figures S6C and
S6D). Lineage tracing from Lgr5+ cells was only observed
when tamoxifen was administered at least 2 weeks prior to radi-
ation, suggesting that Lgr5+ cells can over time give rise to a
radioresistant stem cell population, such as Krt19+ cells. We
demonstrated that Krt19+ cells give rise to Lgr5+ cells (Figures
1G and 1K; Figures S2A and S2E); thus, to our knowledge,
this is the first in vivo evidence that stem cell interconversion
readily occurs between radioresistant (Krt19+) and radiosensitive
(Lgr5+) states.
Radioresistant Krt19+ Cancer-Initiating Cells Are
Functionally Distinct from Lgr5+ Cells
The contribution of Lgr5+ stem cells to early tumor development
has previously been demonstrated by the formation of intestinal
adenomas upon targeted mutation of the Apc gene in this line-
age (5). However, the contribution of additional stem cell pools
to the origin of cancer remains unknown. To determine whether
Krt19+ cells can also function as cancer-initiating cells in the co-
lon and intestine, we generated Krt19-CreERT;R26-LacZ;ApcF/F
mice in which conditional expression of a truncated form of Apc
occurs in Krt19+ cells following tamoxifen induction. Analogous
to Lgr5+ stem cells, Krt19+ cells initiated intestinal tumorigenesis
following Apc deletion, resulting in rapid mortality (Figure 5A). To
functionally distinguish between Krt19+ and Lgr5+ cancer-initi-
ating cells, however, we further compared the susceptibility of
these two stem cell pools to radiation injury. Interestingly,
when irradiated 24 hr after tamoxifen, Lgr5-EGFP-IRES-
CreERT2;R26-LacZ;ApcF/Fmice showed nomortality (Figure 5B)
and normal non-lineage-traced colon and intestine (Figure 5C),
whereas similarly treated Krt19-CreERT;R26-LacZ;ApcF/F mice
continued to display rapid mortality (Figure 5B) from numerous
lineage traced colonic and intestinal tumors (Figure 5D). Taken
together, these observations provide evidence that Krt19+
stem cells are cancer-initiating cells distinct from Lgr5+ cells.
Furthermore, when crypts from Krt19-CreERT; R26-mT/
mG;ApcF/F mice were cultured in vitro 24 hr after tamoxifen,
recombined Apc floxed Krt19+ cells appeared as GFP+ spheroid
structures (Figures 5E and 5F), which were easily distinguishable
from non-recombined crypts that remained Tomato+ and formed
normal budding crypt structures. Consistent with our in vivo
observations, following in vitro irradiation (10 Gy), Apc floxed
Krt19+ spheroids were radioresistant with no change in growth,
and non-recombined Apc wild-type crypts showed radiosensi-
tivity only within the budding crypts that contain Lgr5+ stem cells(Figures 5G–5I). Post-radiation, there was neither in vitro nor
in vivo Lgr5 mRNA expression, while Krt19 mRNA actually
increased (Figures 5J and 6A). Thus, radiosensitive Lgr5+
stem cells are dispensable in both normal and Apc mutated
crypts. Similarly, in Apc floxed tumors of Lgr5-EGFP-IRES-
CreERT2;R26-LacZ;ApcF/F mice, we detected reduced Lgr5-
GFP+ cells, but unchanged Krt19 protein-positive cells 24 hr
post-radiation (Figures 6B and 6C).
When we additionally performed DT ablation of Lgr5+ cancer
stem cells in crypts from Lgr5-DTR-EGFP;Krt19-CreERT;R26-
LacZ;ApcF/F mice, we observed continued growth of many, but
not all, Krt19+ Apc floxed enteroids (Figures 6D–6F). We con-
firmed the efficacy of DT ablation of Lgr5+ cells by the absence
of Lgr5 mRNA expression (Figure 6G), which again was associ-
ated with a corresponding increase in Krt19 mRNA expression
(Figure 6G). Importantly, Krt19+ Apc floxed enteroids could
also be maintained in culture in the absence of R-spondin and
were completely unaffected even by Lgr5+ cell ablation in this
setting (Figures 6H and 6I). These data prove, for the first time,
thatKrt19+ cell-derived Apc floxed enteroids are heterogeneous,
with Lgr5+ cancer stem cells being completely dispensable in
these enteroids (Figures 6I and 6J).
DISCUSSION
In contrast to the intestine, the paucity of stem cell markers in
the colon has hampered our ability to identify and adequately
characterize Lgr5-negative stem cell pools in normal and
neoplastic colonic crypts. Here, we show that Krt19-expressing
cells, extending from the +4 position to the crypt isthmus,
include unique long-lived stem cells that are distinct from
Lgr5+ CBCs. The distinct nature of Krt19+ versus Lgr5+ stem
cells was confirmed by the observation that Krt19+ cells
continue to lineage trace crypts despite ablation of Lgr5+
stem cells in both the colon and intestine. Krt19+ cells actively
contribute to normal epithelial maintenance and are also clearly
functionally distinct from Lgr5+ stem cells by their relative radio-
resistance. The radioresistance of Krt19+ cells holds true not
only in the colon but also in the intestine. Recognizing that
Krt19-expressing cells comprise a heterogeneous population
that also includes progenitor and TA cells, we confirmed that
the differences in radiation response were nonetheless attribut-
able to Krt19+ stem cells. Indeed, the combination of TA cell tar-
geting by 5-FU and DT ablation of Lgr5+ cells confirmed that a
unique population of Krt19+ stem cells continue to lineage trace
and expand following radiation injury. Notably, in the intestine, it
has been shown that Dll1+ progenitors and Bmi1+ stem cells are
radioresistant (van Es et al., 2012; Yan et al., 2012), while Lgr5+
stem cells are radiosensitive. Interestingly, our observations
regarding Krt19+ cell radioresistance now extend these findings
to the colon, where Bmi1+ and Dll1+ cells are not found (San-
giorgi and Capecchi, 2008; van Es et al., 2012). Moreover,
Krt19+ cells lineage trace independent of Lgr5+ cells following
radiation injury, as Lgr5+ stem cells are radiosensitive when
irradiated 24 hr following tamoxifen induction. Taken together
with the recent observations of Metcalfe et al. (2014), the
rapid regeneration of Lgr5+ cells in the immediate post-radiation
period is essential for epithelial repair and likely to occur from a
radioresistant Krt19+ population. Thus, long-lived radioresistantCell Stem Cell 16, 627–638, June 4, 2015 ª2015 Elsevier Inc. 633
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Figure 4. Krt19+ Cells Expand in Response to Injury and Display Relative Radioresistance Compared to Lgr5+ Stem Cells
(A) To examine the radiosensitivity of Krt19+ and Lgr5+ stem cells, mice were irradiated 24 hr after tamoxifen, and lineage tracing was examined 2 months
following tamoxifen.
(B and C) Representative b-gal+ intestinal crypts in Lgr5-EGFP-IRES-CreERT2;R26RLacZ (B) versus Krt19-CreERT;R26RLacZ (C) mice irradiated (12 Gy) 24 hr
post-tamoxifen.
(D) Quantification of contiguously labeled b-gal+ Krt19 (top) versus Lgr5- (bottom) labeled crypts following irradiation 24 hr after tamoxifen.
(E and F) Representative small intestinal crypt-villus image of Lgr5-EGFP-IRES-CreERT2;R26RLacZ mice following high-dose radiation exposure demonstrating
the disappearance of Lgr5-EGFP+ crypt-based columnar cells 24 hr following irradiation (E) and re-emergence of EGFP+ CBCs 7 days following irradiation (F).
(legend continued on next page)
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Figure 5. Radioresistant Krt19+ Cancer-
Initiating Cells Are Functionally Distinct
from Lgr5+ Stem Cells
(A) Krt19+ and Lgr5+ stem cells both serve as
cancer-initiating cells, resulting in rapid mortality in
Krt19-CreERT;R26-LacZ;ApcF/F or Lgr5-EGFP-
IRES-CreERT2;R26-LacZ;ApcF/F mice.
(B–D) Lgr5-EGFP-IRES-CreERT2;R26-LacZ;ApcF/F
mice irradiated 24 hr after tamoxifen show no
mortality (B) and normal non-lineage-traced intes-
tine (left) and colon (right) (C). In contrast, Krt19-
CreERT;R26-LacZ;ApcF/F mice irradiated 24 hr
after tamoxifen continue to show rapidmortality (B)
from intestinal (left) and colonic (right) tumors (D);
(nR 6 per group).
(E and F) Bright-field (E) and fluorescent (F) images
of intestinal crypts from Krt19-CreERT;R26-mT/
mG;ApcF/F cultured in vitro 24 hr after tamoxifen.
Arrows point to recombined GFP+ Apc floxed
Krt19+ cells appearing as spheroid structures.
(G) In vitro radiation protocol used to examine the
effects of radiation injury on intestinal Krt19+ cell-
derived Apc floxed tumor populations.
(H) Krt19+ cell-derived Apc floxed tumor pop-
ulations pre- (day 0) and post- (day 2 and day 7)
radiation (10 Gy).
(I) Quantification of surviving Krt19+ cell-derived
APC floxed enteroids pre- and post-radiation
injury.
(J) Krt19 and Lgr5 mRNA expression levels in
Krt19+ cell-derived Apc floxed enteroids pre- and
post-radiation injury.
Data in all bar graphs are presented as
mean ± SEM.Krt19+ cells are functionally distinct from radiosensitive Lgr5+
CBCs in both the colon and intestine.
Recent work by Takeda et al. (2011) suggested that intercon-
version between two or more stem cell pools occurs in enteroid
cultures. Here, we demonstrate thatKrt19+ stem cells give rise to
Lgr5+ CBCs in both the colon and intestine and that the reverse is
also true. That is, radiosensitive Lgr5+ stem cells give rise to
Krt19+ radioresistant cells, given enough time to interconvert
following tamoxifen. Therefore, although previously speculated
to be true, we provide the first in vivo evidence that Lgr5+ cells(G) In vivo 5-FU (150 mg/kg) protocol used to examine the effects of TA cell ablation on Krt19+ stem cell lin
(H) Representative low (left) and high (right) power images of Krt19+ cell lineage tracing in Krt19-CreERT;R26R
post-radiation.
(I) In vitro radiation protocol used to examine the effects of radiation injury on intestinal Krt19 and Lgr5 stem
(J) Bright-field (top) and fluorescent (bottom) images of intestinal enteroids from Krt19-mApple+/ Lgr5-GFP
post-radiation (10 Gy).
(K) Radiation protocol used to examine Lgr5-derived lineage tracing in Lgr5-EGFP-IRES-CreERT2/R26RLac
(L and M) b-gal+ intestinal crypts from control (L) versus irradiated (M) Lgr5-EGFP-IRES-CreERT2;R26RLac
(N) Quantification of contiguously labeled b-gal+ Lgr5-labeled crypts following irradiation 2 weeks after tam
Data in all bar graphs are presented as mean ± SEM.
See also Figure S6.
Cell Stem Cell 16, 627–can indeed give rise to a radioresistant
stem cell population (Figures 4 and S6).
Although the colon was the predomi-
nant focus of the current study, thepotential overlap of Krt19 with other +4 intestinal stem cell
markers or Dll1+ progenitors raises the possibility that some
of our observations in the intestine could be attributed to over-
lap with these cell populations. It is important to note, how-
ever, that intestinal Krt19+ cells are long lived, survive well
beyond 18 months, and show lineage tracing capacity even
when irradiated 2 weeks following tamoxifen induction. This
is true, not only in the colon but also in the intestine, where
this is in sharp contrast to intestinal Dll1+ progenitors that
are short lived and do not display any lineage tracing capacityeage tracing.
LacZ mice treated with 5-FU and examined 8 days
cell populations.
+ double transgenic mice cultured in vitro pre- and
Z mice 2 weeks after tamoxifen.
Z mice.
oxifen; (nR 5 per group).
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Figure 6. Lgr5+ Stem Cells Are Radiosensi-
tive within Colonic Tumors, Unlike Krt19+
Cells, which Are Radioresistant
(A) In vivo Krt19 and Lgr5 mRNA in Apc floxed
tumors pre- or post- (24 hr and 7 days) radiation;
* indicates p < 0.05 versus control; (n R 4 per
group).
(B and C) Lgr5-GFP+ (B) and Krt19 immunopositive
(C)cells inApcfloxed tumorspre-orpost-radiation-
induced targeting of Lgr5+ cells.
(D) In vitro Lgr5+ cell ablation protocol used to
examine the dispensability of Lgr5+ cells in Krt19+
cell-derivedApc floxed enteroids from Lgr5-EGFP-
DTR;Krt19-CreERT;ApcF/F mice.
(E) Bright-field images of intestinal enteroids from
Lgr5-EGFP-DTR;Krt19-CreERT;ApcF/F mice pre-
(day 0) and post- (day 2 and day 7) DT ablation of
Lgr5+ cells.
(F) Quantification of surviving Krt19+ cell-derived
WT and APC floxed enteroids pre- and post-Lgr5+
cell ablation.
(G) Krt19 and Lgr5 mRNA expression levels in
Krt19+ cell-derived APC floxed enteroids pre- and
post- (48 hr) Lgr5+ cell ablation (G); ** indicates p <
0.01 versus control; (nR 4 per group).
(H) Bright-field images of Krt19+ cell-derived APC
floxed intestinal enteroids from Lgr5-EGFP-
DTR;Krt19-CreERT;ApcF/F mice cultured in the
presence (DT) or absence (+DT) of Lgr5+ cell
ablation.
(I) Quantification of surviving Krt19+ cell-derived
APC floxed enteroids pre- and post-Lgr5+ cell
ablation and cultured in the presence/absence of
growth factors.
(J) Krt19 and Lgr5 mRNA expression levels in
Krt19+ cell-derived APC floxed enteroids grown in
the presence or absence of standard growth fac-
tors (R-spondin and noggin), pre- and post- (48 hr)
Lgr5+ cell ablation; (nR 4 per group).
Data in all bar graphs are presented as
mean ± SEM.when irradiated beyond 24 hr following tamoxifen (van Es
et al., 2012). Moreover, Krt19+ cells remained capable of sus-
taining intestinal enteroids in vitro, despite ablation of Lgr5+
stem cells and the absence of Wnt3a (a factor recently shown
to be essential for Dll1+ progenitor reversion to stem cells).
Furthermore, our RNA expression analysis revealed that the
overlap of Krt19 with the various +4 intestinal stem cell
markers, as well as Dll1, was only true of rare Krt19+/Lgr5+
double-positive cells above the CBCs, yet DT ablation of all
Lgr5+ cells, including this overlapping population had no effect
on Krt19+ stem cell lineage tracing activity. Taken together,
these data prove that overlap with Dll1+ progenitors and
Bmi1+ stem cells cannot solely explain our observations
regarding radioresistance of Krt19+ cells in the intestine.
Ritsma et al. (2014) recently suggested that Lgr5+ cells display
heterogeneity based on their ‘‘border’’ versus ‘‘central’’ position
within the intestinal crypt. Our own observations that a rare sub-
set of Lgr5+ cells expresses Krt19, while the majority of Lgr5+
cells do not, supports the premise of heterogeneity among
Lgr5+ cells and, additionally, leads one to speculate whether636 Cell Stem Cell 16, 627–638, June 4, 2015 ª2015 Elsevier Inc.Krt19-mApple+/ Lgr5-GFP+ double-positive cells identify a
unique subset of Lgr5+ cells with ‘‘potential’’ stem cell activity
as previously described (Kozar et al., 2013).
Conditional expression of a truncated form of Apc additionally
confirmed that Krt19+ cells include a population of cancer-
initiating cells. That cancer initiation in Lgr5-EGFP-IRES-
CreERT2;R26-LacZ;ApcF/F mice was completely suppressed in
the colon, as well as the intestine, by high-dose radiation 24 hr
following tamoxifen confirmed that Lgr5+ cancer-initiating
cells were radiosensitive. In contrast, similarly treated Krt19-
CreERT;R26-LacZ;ApcF/F mice developed many colonic and
intestinal tumors despite irradiation, again demonstrating the
functional distinction of Krt19+ versus Lgr5+ cancer-initiating
cells. Thus, we provide the first definitive evidence of an
Krt19+/Lgr5() radioresistant cancer-initiating cell population in
both the colon and intestine. In view of the high prevalence of
colon cancer and inflammatory conditions affecting the colon,
the identification of colonic Krt19+/Lgr5() cancer-initiating
stem cells is highly relevant to our understanding and treatment
of human disease. Additionally, we now demonstrate that Lgr5+
cancer stem cells are dispensable in Apc floxed tumors, partic-
ularly in R-spondin-independent conditions. In view of the recent
findings that R-spondin fusion proteins activate Wnt signaling in
a subset of human colorectal tumors, our observationsmay have
important implications for Lgr5+ cell-targeted therapy in subsets
of colorectal cancer patients (Seshagiri et al., 2012).
In summary, we identify a novel population of colonic Krt19+
cells that give rise to Lgr5+ CBC cells. RadioresistantKrt19+ cells
located above the crypt base can initiate cancer and are func-
tionally distinct from radiosensitive Lgr5+ CBCs. These findings
have important clinical relevance for future cancer therapy tar-
geting colonic stem cell populations.
EXPERIMENTAL PROCEDURES
Generation of Krt19-CreERT2 Transgenic Mice
For BAC recombineering, the K19 containing BAC clone (BAC RP-23-
24N13) was transformed into SW105 competent cells and a Krt19-BAC-
CreERT2 construct generated by BAC recombineering. All animal studies
were performed in Institutional Animal Care and Use Committee (IACUC)-
approved facilities and completed in accordance to IACUC protocols at
Columbia University. See Supplemental Experimental Procedures for
further details.
Lineage Tracing Analysis, Assessment, and Immunofluorescence
Intestinal and colonic tissues were prepared as Swiss rolls and sections fixed
with 4% paraformaldehyde and b-galactosidase labeling assessed by X-gal
staining of frozen sections taken from R26rLacZ mice. Mice were sacrificed
at various time points post-tamoxifen and analyzed at the time points speci-
fied. We similarly analyzed tissues from R26-mT/mG reporter mice for
EGFP-positive cells and their progeny at various time points post-tamoxifen.
Further details are outlined in the Supplemental Experimental Procedures.
For immunostaining, we performed staining of frozen sections with antibodies
according to the methods detailed in the Supplemental Experimental
Procedures.
Flow Cytometry
Single-cell suspensions were stained with antibodies and analyzed on FACS
Calibur, Aria III (BD) or Gallios (Beckman Coulter). FlowJo software (Ashland)
was used for data analysis. Detailed methods and antibodies are described
in the Supplemental Experimental Procedures.
In Situ Hybridization
UsingacRNAprobeconstructedand labeled forKrt19, paraformaldehyde-fixed
small intestine (SI) and colonic tissues were hybridized with the probe. Detailed
methods and antibodies are described in the Supplemental Experimental
Procedures.
Statistical Analysis
Statistical analysis was performed with Student’s t test or Mann-Whitney when
comparing two groups or standard ANOVA analysis with Bonferri correction.
Values of * (p < 0.05) and ** (p < 0.01) were considered statistically significant.
Enteroid In Vitro Cultures
Intestinal or colonic glands units were isolated from mouse as previously
described by Bjerknes and Cheng (2006) with some modifications and
cultured in the presence of EGF 50 ng/ml (Invitrogen), mNoggin 100 ng/ml
(Peprotech), and R-Spondin 1 mg/ml as previously described (Sato et al.,
2009). Detailed protocols are described in the Supplemental Experimental
Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
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